Clinico-pathological correlations of the most common neurodegenerative dementias

Frontiers in Neurology

Volumn MAY, Issue , 2012, Pages

  Taipa, Ricardo ^a   Pinho, João ^b   Melo Pires, Manuel ^a  

^a HOSPITAL DE SANTO ANTÓNIO   (Portugal)

^b HOSPITAL DE BRAGA   (Portugal)

Author keywords

Clinical syndromes; Neurodegenerative dementia; Neuropathology

Indexed keywords

EID: 84865987127     PISSN: None     EISSN: 16642295     Source Type: Journal    
DOI: 10.3389/fneur.2012.00068     Document Type: Article

References (146)

1. Aarsland, D., and Kurz, M. W. (2010). The epidemiology of dementia associated with Parkinson's disease. Brain Pathol. 20, 633-639.
2. Aarsland, D., Zaccai, J., and Brayne, C. (2005). A systematic review of prevalence studies of dementia in Parkinson's disease. Mov. Disord. 20, 1255-1263.
3. Alafuzoff, I., Ince, P. G., Arzberger, T., Al-Sarraj, S., Bell, J., Bodi, I., Bogdanovic, N., Bugiani, O., Ferrer, I., Gelpi, E., Gentleman, S., Giac-cone, G., Ironside, J. W., Kavantzas, N., King, A., Korkolopoulou, P., Kovács, G. C., Meyronet, D., Mono-ranu, C., Parchi, P., Parkkinen, L., Patsouris, E., Roggendorf, W., Rozemuller, A., Stadelmann-Nessler, C., Streichenberger, N., Thal, D. R., and Kretzschmar, H. (2009). Staging/typing of Lewy body related alpha-synuclein pathology: a study of the BrainNet Europe Consortium. Acta Neuropathol. 117, 635-652.
4. Alladi, S., Xuereb, J., Bak, T., Nestor, P., Knibb, J., Patterson, K., and Hodges, J. R. (2007). Focal cortical presentations of Alzheimer's disease. Brain 130, 2636-2645.
5. Al-Sarraj, S., King, A., Troakes, C., Smith, B., Maekawa, S., Bodi, I., Rogelj, B., Al-Chalabi, A., Horto-bágyi, T., and Shaw, C. E. (2011). p62 positive, TDP-43 negative, neu-ronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS. Acta Neuropathol. 122, 691-702.
6. American Psychiatric Association. (2000). Diagnosis and Statistic Manual of Mental Disorders (IV-TR), 4th Edn. Washington, DC: Amer Psychiatric Pub.
7. Anstey, K. J., von Sanden, C., Salim, A., and O'Kearney, R. (2007). Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies. Am. J. Epidemiol. 166, 367-378.
8. Arendt, T. (2009). Synaptic degeneration in Alzheimer's disease. Acta Neuropathol. 118, 167-179.
9. Armstrong, T. P., Hansen, L. A., Salomon, D. P., Masliah, E., Pay, M., Kunin, J. M., and Katzman, R. (1991). Rapidly progressive dementia in a patient with Lewy body variant of Alzheimer's disease. Neurology 41, 1178-1180.
10. Arnold, S. E., Hyman, B. T., Flory, J., Damasio, A. R., and Van Hoesen, G. W. (1991). The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb. Cortex 1, 103-116.
11. Ballard, C., Gauthier, S., Corbett, A., Brayne, C., Aarsland, D., and Jones, E. (2011). Alzheimer's disease. Lancet 377, 1019-1031.
12. Benson, F., Davis, J., and Snyder, B. D. (1998). Posterior cortical atrophy. Arch. Neurol. 45, 789-793.
13. Bertram, L. (2008). " Dementias," in Handbook of Clinical Neurology, Vol. 89, 3rd series, eds C. Duyckaerts and I. Litvan (Amsterdam: Elsevier), 223-232.
14. Bertram, L. (2011). Alzheimer's genetics in the GWAS era: a continuing story of 'replications and refutations.' Curr. Neurol. Neurosci. Rep. 11, 246-253.
15. Biessels, J. G., Staekenborg, S., Brun-ner, E., Brayne, C., and Scheltens, P. (2006). Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 5, 64-74.
16. Boeve, B. F., Lang, A. E., and Litvan, I. (2003). Corticobasal degeneration and its relationship to progressive supranuclear palsy and fron-totemporal dementia. Ann. Neurol. 54(Suppl. 5), S15-S19.
17. Braak, H., and Braak, E. (1991). Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82, 239-259.
18. Braak, H., Del Tredici, K., Rüb, U., de Vos, R. A., Jansen Steur, E. N., and Braak, E. (2003). Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging 24, 197-211.
19. Braak, H., and Tredici, K. D. (2004). Alzheimer's disease: intraneu-ronal alterations precede insoluble amyloid-β formation. Neurobiol. Aging 25, 713-718.
20. Braak, H., and Tredici, K. D. (2011). Alzheimer's pathogenesis: is there neuron to neuron propagation? Acta Neuropathol. 121, 589-595.
21. Bronner, I. F., ter Meulen, B. C., Azmani, A., Severijnen, L. A., Willemsen, R., Kamphorst, W., Ravid, R., Heutink, P., and van Swieten, J. C. (2005). Hereditary Pick's disease with the G272V tau mutation shows predominant three-repeat tau pathology. Brain 128, 2645-2653.
22. Cairns, N. J., Bigio, E. H., Mackenzie, I. R., Neumann, M., Lee,V. M., Hatanpaa, K. J., White, C. L. III, Scheinder, J. A., Grinberg, L. T., Halliday, G., Duyckaerts, C., Lowe, J. S., Holm, I. E., Tolnay, M., Okamoto, K., Yokoo, H., Murayama, S., Woulfe, J., Munoz, D. G., Dickson, D. W., Ince, P. G., Trojanowski, J. Q., Mann, D. M., andConsortiumforFrontotemporal Lobar Degeneration. (2007). Neu-ropathologic diagnostic and noso-logic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotempo-ral Lobar Degeneration. Acta Neu-ropathol. 114, 5-22.
23. Callahan, L. M., Vaules, W. A., and Coleman, P. D. (1999). Quantitative decrease in synaptophysin message expression and increase in cathepsin D message expression in Alzheimer disease neurons containing neu-rofibrillary tangles. J. Neuropathol. Exp. Neurol. 58, 275-287.
24. Casanova, M. F., Starkstein, S. E., and Jellinger, K. A. (2011). Clinicopatho-logical correlates of behavioral and psychological symptoms of dementia. Acta Neuropathol. 122, 117-135.
25. Davidson, Y., Kelley, T., Mackenzie, I. R., Pickering-Brown, S., Du Plessis, D., Neary, D., Snowden, J. S., and Mann, D. M. (2007). Ubiquitinated pathological lesions in frontotempo-ral lobar degeneration contain the TAR DNA-binding protein, TDP-43. Acta Neuropathol. 113, 521-533.
26. de la Torre, J. C. (2011). Three postulates to help identify the cause of Alzheimer's disease. J. Alzheimers Dis. 24, 657-668.
27. DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A.M.,Finch, N. A., Flynn, H.,Adamson, J., Kouri, N., Wojtas, A.,Sengdy, P., Hsiung, G. Y., Kary-das, A., Seeley, W. W., Josephs, K.A., Coppola, G., Geschwind, D. W.,Wszolek, Z. K., Feldman, H., Knop-man, D. S., Petersen, R. C., Miller, L., Dickson, D. W., Boylan, K. B.,Graff-Radford, N. R., and Rademakers, R. (2011). Expanded GGGGCChexanucleotide repeat in noncod-ing region of C9ORF72 causes chromosome 9p-linked FTD and ALS.Neuron 72, 245-256.
28. Delacorte, A., Sergeant, N., Wattez, A., Gauvreau, D., and Robittaile, Y. (1998). Vulnerable neuronal subsets in Alzheimer's disease and Pick's disease are distinguished by their tau isoform distribution and phospho-rylation. Ann. Neurol. 43, 193-204.
29. Delaère, P., Duyckaerts, C., He,Y., Piette, F., and Hauw, J. J. (1991). Subtypes and differential laminar distribution of βA4 deposits in Alzheimer's disease: relationship with the intellectual status of 26 cases. Acta Neu-ropathol. 81, 328-335.
30. Dickson, D. W. (2001). Neuropathol-ogy of Pick's disease. Neurology 56(Suppl. 4), S16-S20.
31. Dickson, D. W. (2010). Neuropathology of non-Alzheimer degenerative disorders. Int. J. Clin. Exp. Pathol. 3, 1-23.
32. Dickson, D. W. (2011). " Introduction to neurodegeneration: the molecular pathology of dementia and movement disorders," in Neurodegener-ation: The Molecular Pathology of Dementia and Movement Disorders, eds D. W. Dickson and R. O. Weller (Chichester: Wiley-Blackwell), 3-5.
33. Dickson, D. W., Bergeron, C., Chin, S. S., Duyckaerts, C., Horoupian, D., Ikeda, K., Jellinger, K., Lantos, P. L., Lippa, C. F., Mirra, S. S., Tabaton, M., Vonsattel, J. P., Wakabayashi, K., and Litvan, I. (2002). Office of rare diseases neuropathologic criteria for corticobasal degeneration. J. Neu-ropathol. Exp. Neurol. 61, 935-946.
34. Dickson, D. W., Braak, H., Duda, J. E., Duyckaerts, C., Gasser, T., Halliday, G. M., Hardy, J., Leverenz, J. B., Del Tredici, K., Wszolek, Z. K., and Litvan, I. (2009). Neuropathologi-cal assessment of Parkinson's disease: refining the diagnostic criteria. Lancet Neurol. 8, 1150-1157.
35. Dickson, D. W., Kouri, N., Murray, M. E., and Josephs, K. A. (2011b). Neuropathology of fron-totemporal lobar degeneration-tau (FTLD-Tau). J. Mol. Neurosci. 45, 384-489.
36. Dolan, H., Crain, B., Troncoso, J., Resnick, S. M., Zonderman, A. B., and O'Brien, R. J. (2010). Atherosclerosis, dementia, and Alzheimer disease in the Baltimore Longitudinal Study of Aging cohort. Ann. Neurol. 68, 231-240.
37. Dubois, B., Feldman, H. H., Jacova, C., Cummings, J. L., DeKosky, S. T., Barbeger-Gateau, P., Delacourte, A., Frisoni, G., Fox, N. C., Galasko, D., Gauthier, S.,Hampel, H., Jicha,G.A., Meguro, K., O'Brien, J., Pasquier, F., Robert, P., Rossor, M., Salloway, S., Sarazin, M., de Sousa, L. C., Stern, Y., Visser, P. J., and Scheltens, P. (2010). Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurol. 9, 1118-1127.
38. Dubois, B., Feldman, H. H., Jacova, C., DeKosky, S. T., Barbeger-Gateau, P., Cummings, J., Delacourte, A., Galasko, D., Gauthier, S., Jicha, G., Meguro, K., O'Brien, J., Pasquier, F., Robert, P., Rossor, M., Salloway, S., Stern, Y., Visser, P. J., and Schel-tens, P. (2007). Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 6, 734-746.
39. Duyckaerts, C., Delatour, B., and Potier, M. C. (2009). Classification and basic pathology of Alzheimer disease. Acta Neuropathol. 118, 5-36.
40. Duyckaerts, C., and Hauw, J. J. (1997). Diagnosis and staging of Alzheimer disease. Neurobiol. Aging 18, S33-S42.
41. Emre, M., Arsland, D., Brown, R., Burn, D. J., Duyckaerts, C., Mizuno, Y., Broe, G. A., Cummings, J., Dick-son, D. W., Gauthier, S., Goldman, J., Goetz, C., Korczyn, A., Lees, A., Levy, R., Litvan, I., McKeith, I., Olanow, W., Poewe, W., Quinn, N., Sam-paio, C., Tolosa, E., and Dubois, B. (2007). Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov. Disord. 22, 1689-1707.
42. Ferri, C. P., Prince, M., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., Hall, K., Hasegawa, K., Hendrie, H., Huang, Y., Jorm, A., Mathers, C., Menezes, P. R., Rimmer, E., and Scazufca, M. (2005). Global preve-lance of dementia: a Delphi consensus study. Lancet 366, 2112-2117.
43. Forman, M. S., Trojanowski, J. Q., and Lee, V. M. (2004). Neurodegenera-tive diseases: a decade of discoveries paves the way for therapeutic breakthroughs. Nat. Med. 10, 1055-1063.
44. Fritze, F., Ehrt, U., Sønnesyn, H., Kurz, M., Hortobágyi, T., Nore, S. P., Bal-lard, C., and Aarsland, D. (2011). Depression in mild dementia: associations with diagnosis, APOE genotype and clinical features. Int. J. Geriatr. Psychiatry 26, 1054-1061.
45. Gaig, C., Valldeoriola, F., Gelpi, E., Ezquerra, M., Llufriu, S., Buon-giorno, M., Rey, M. J., Martí, M. J., Graus, F., and Tolosa, E. (2011). Rapidly progressive diffuse Lewy body disease. Mov. Disord. 26, 1316-1323.
46. Gelb, D. J., Oliver, E., and Gilman, S. (1999). Diagnostic criteria for Parkinson's disease. Arch. Neurol. 56, 33-39.
47. Ghetti, B., Wszolek, Z. K., Boeve, B. F., Spina, S., and Goedert, M. (2011). " Frontotemporal dementia andparkinsonism linkedtochromo-some 17," in Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders, eds D. W. Dick-son and R. O. Weller (Chichester: Wiley-Blackwell), 110-134.
48. Giannakopoulos, G., von Gunten, A., Kövari, E., Gold, G., Herrmann, F. R., Hof, P. R., and Bouras, C. (2007). Stereological analysis of neuropil threads in the hippocampal formation: relationships with Alzheimer's disease neuronal pathology and cognition. Neuropathol. Appl. Neurobiol. 33, 334-343.
49. Gibb, W. R., and Lees, A. J. (1998). The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J. Neurol. Neurosurg. Psychiatr. 51, 745-752.
50. Gomez-Isla, T., Price, J. L., McKeel, D. W., Morris, J. C., Growdon, J. H., and Hyman, B. T. (1996). Profound loss of layer II entorhinal cortex neurons occur in very mild Alzheimer's disease. J. Neurosci. 16, 4491-4500.
51. Gomez-Isla, T., Spires, T., Calignon, A., and Hyman, B. T. (2008). " Dementias," in Handbook of Clinical Neurology, Vol. 89, 3rd series, eds C. Duy-ckaerts and I. Litvan (Amsterdam: Elsevier), 233-243.
52. Gorno-Tempini, M. L., Brambati, S. M., Ginex, V., Ogar, J., Dronker, N. F., Marcone, A., Perani, D., Garibotto, V., Cappa, S. F., and Miller, B. L. (2008). The logopenic/phonologic variant of primary progressive aphasia. Neurology 71, 1227-1234.
53. Gorno-Tempini, M. L., Hillis, A. E., Weintraub, S., Kertesz, A., Mendez, M., Cappa, S. F., Ogar, J. M., Rohrer, J. D., Black, S., Boeve, B. F., Manes, F., Dronkers, N. F., Vandenberghe, R., Rascovsky, K., Patterson, K., Miller, B. L., Knopman, D. S., Hodges, J. R., Mesulam, M. M., and Grossman, M. (2011). Classification of primary progressive aphasia and its variants. Neurology 76, 1006-1014.
54. Greene, J. D., Patterson, K., Xuereb, J., and Hodges, J. R. (1996). Alzheimer disease an nonfluent progressive aphasia. Arch. Neurol. 53, 1072-1078.
55. Grignon, Y., Duyckaerts, C., Ben-necib, M., and Hauw, J. J. (1998). Cytoarchitectonic alterations in the supramarginal gyrus of late onset Alzheimer's disease. Acta Neu-ropathol. 95, 395-406.
56. Grossman,M. (2010). Primary progressive aphasia: clinicopathological correlations. Nat. Rev. Neurol. 6, 88-97.
57. Haik, S., Brandel, J. P., Sazdovitch, V., Delasnerie-Lauprêtre, N., Peoc'h, K., Laplanche, J. L., Privat, N., Duyck-aerts, C., Kemeny, J. L., Kopp, N., Laquerrière, A., Mohr, M., Deslys, J. P., Dormont, D., and Hauw, J. J. (2000). Dementia with Lewy bodies in a neuropathologic series of suspected Creutzfeldt-Jakob disease. Neurology 55, 1401-1404.
58. Halliday, G., Hely, M., Reid, W., and Morris, J. (2008). The progression of pathology in longitudinally followed patients with Parkinson's disease. Acta Neuropathol. 115, 409-415.
59. Halliday, G. M., Holton, J. L., Revesz, T., and Dickson, D. W. (2011). Neuropathology underlying clinical variability in patients with synucle-inopathies. Acta Neuropathol. 122, 187-204.
60. Halliday,G.M.,and McCann,H.(2010). The progression of pathology in Parkinson's disease. Ann. N. Y. Acad. Sci. 1184, 188-195.
61. Hamilton, R. L. (2000). Lewy bodies inAlzheimer's disease: a neuropatho-logical review of 145 cases usingalpha-synuclein immunohisto-chemistry. Brain Pathol. 10, 378-384.
62. Hardy, J. A., and Higgins, G. A. (1992). Alzheimer's disease: the amyloid cascade hypothesis. Science 256, 184-185.
63. Hauw, J. J., Daniel, S. E., Dickson, D., Horoupian, D. S., Jellinger, K., Lantos, P. L., McKee, A., Tabaton, M., and Litvan, I. (1994). Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 44, 2015-2019.
64. Hodges, J. R., Davies, R. R., Xuereb, J. H., Casey, B., Broe, M., Bak, T. H., Kril, J. J., and Halliday, G. M. (2004). Clin-icopathological correlates in fron-totemporal dementia. Ann. Neurol. 56, 399-406.
65. Hof, P. R., Vogt, B. A., Bouras, C., and Morrison, J. H. (1997). Atypical form of Alzheimer's disease with prominent posterior cortical atrophy: a review of lesion distribution and circuit disconnection in cortical visual pathways. Vision Res. 37, 3609-3625.
66. Hurtig, H. I., Trojanowski, J. Q., Galvin, J.,Ewbank, D., Schmidt,M. L., Lee,V. M., Clark, C. M., Glosser, G., Stern, M. B., Gollomp, S. M., and Arnold, S. E. (2000). Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease. Neurology 54, 1916-1921.
67. Hyman, B. T., and Trojanowski, J. Q. (1997). Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J. Neuropathol. Exp. Neurol. 56, 1095-1097.
68. Ikeda, K. (1997). Basic pathology of corticobasal degeneration. Neu-ropathology 17, 127-133.
69. Ince, P. G. (2011). " Dementia with Lewy bodies and Parkinson's disease dementia," in Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders, eds D. W. Dickson and R. O. Weller (Chich-ester: Wiley-Blackwell), 224-241.
70. Jellinger, K. A. (2008). A critical reappraisal of current staging of Lewy-related pathology in human brain. Acta Neuropathol. 116, 1-16.
71. Jellinger, K. A. (2009). Criteria for the neuropathological diagnosis of dementing disorders: routes out of the swamp? Acta Neuropathol. 117, 101-110.
72. Jellinger, K. A., and Attems, J. (2011a). Rapidly progressing diffuse Lewy body disease. Mov. Disord. 26, 2584-2585.
73. Jellinger, K. A., and Kovacs, G. G. (2011b). Clinico-pathological correlations in neurodegeneration. Acta Neuropathol. 122, 115-116.
74. Johnson, J. K., Head, E., Kim, R., Starr, A., and Cotman, C. W. (1999). Clinical and pathological evidence for a frontal variant of Alzheimer disease. Arch. Neurol. 56, 1233-1239.
75. Josephs, K. A., and Dickson, D. W. (2003). Diagnostic accuracy of progressive supranuclear palsy in the Society for Progressive Supranuclear Palsy brain bank. Mov. Disord. 18, 1018-1026.
76. Josephs, K. A., Hodges, J. R., Snowden, J. S., Mackenzie, I. R., Neumann, M., Mann, D. M., and Dickson, D. W. (2011). Neuropathological background of phenotypical variability in frontotemporal dementia. Acta Neuropathol. 122, 137-153.
77. Josephs, K. A., Petersen, R. C., Knop-man, D. S., Boeve, B. F., Whitwell, J. L., Duffy, J. R., Parisi, J. E., and Dick-son, D. W. (2006). Clinicopatho-logic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology 66, 41-48.
78. Josephs, K. A., Whitwell, J. L., Parisi, J. E., Petersen, R. C., Boeve, B. F., Jack, C. R. Jr., and Dickson, D. W. (2010). Caudate atrophy on MRI is a characteristic feature of FTLD-FUS. Eur. J. Neurol. 17, 969-975.
79. Kalaitzakis, M. E., Graeber, M. B., Gentleman, S. M., and Pearce, R. K. (2009). Evidence against a reliable staging system of alpha-synuclein pathology in Parkinson's disease. Neuropathol. Appl. Neurobiol. 35, 125-126.
80. Kertesz, A. (2003). Pick complex: an integrative approach to frontotem-poral dementia: primary progressive aphasia, corticobasal degeneration and progressive supranuclear palsy. Neurologist 9, 311-317.
81. Kertesz, A., Davidson, W., and Munoz, D. G. (1999). Clinical and pathological overlap between frontotemporal dementia, primary progressive aphasia and corticobasal degeneration: the Pick complex. Dement. Geriatr. Cogn. Disord. 10(Suppl. 1), 46-49.
82. Kertesz, A., McMonagle, P., Blair, M., Davidson, W., and Munoz, D. G. (2005). The evolution and pathology of frontotemporal dementia. Brain 128, 1996-2005.
83. Knibb, J. A., Xuereb, J. H., Patterson, K., and Hodges, J. R. (2006). Clinical and pathological characterization of progressive aphasia. Ann. Neurol. 59, 156-165.
84. Kövari, E., Gold, G., Herrmann, F. R., Canuto, A., Hof, P. R., Bouras, C., and Giannakopoulos, P. (2003). Lewy body densities in the entorhi-nal and anterior cingulate cortex predict cognitive deficits in Parkinson's disease. Acta Neuropathol. 106, 83-88.
85. Kövari, E., Horvath, J., and Bouras, C. (2009). Neuropathology of Lewy body disorders. Brain Res. Bull. 80, 203-210.
86. Lee, E. B. (2011). Obesity, leptin and Alzheimer's disease. Ann. N. Y. Acad. Sci. 1243, 15-29.
87. Lee, E. B., Lee, V. M., and Trojanowski, J. Q. (2011a). Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration. Nat. Rev. Neu-rosci. 13, 38-50.
88. Lee, S. E., Rabinovici, G. D., Mayo, M. C., Wilson, S. M., Seeley, W. W., DeArmond, S. J., Huang, E. J., Tro-janowski, J. Q., Growdon, M. E., Jang, J. Y., Sidhu, M., See, T. M., Karydas, A. M., Gorno-Tempini, M. L., Boxer, A. L., Weiner, M. W., Geschwind, M. D., Rankin, K. P., and Miller, B. L. (2011b). Clinico-pathological correlations in corti-cobasal degeneration. Ann. Neurol. 70, 327-340.
89. Lee, V. M., Goedert, M., and Tro-janowski, J. Q. (2001). Neurode-generative tauopathies. Annu. Rev. Neurosci. 24, 1121-1159
90. Levine, D. N., Lee, J. M., and Fisher, C.M. (1993). The visual variant of Alzheimer's disease: clinico-pathologic case study. Neurology 43,305-313.
91. Ling, H., O'Sullivan, S. S., Holton, J. L., Revesz, T., Massey, L. A., Williams, D.R., Paviour, D. C., and Lees, A. J.(2010). Does corticobasal degeneration exist? A clinicopathological re-evaluation. Brain 133, 2045-2057.
92. Lippa, C. F., Duda, J. E., Grossman, M., Hurtig, H. I., Aarsland, D., Boeve, B. F., Brooks, D. J., Dickson, D. W., Dubois, B., Emre, M., Fahn, S., Farmer, J. M., Galasko, D., Galvin, J. E., Goetz, C. G., Growdon, J. H., Gwinn-Hardy, K. A., Hardy, J., Heutink, P., Iwatsubo, T., Kosaka, K., Lee, V. M., Leverenz, J. B., Masliah, E., McKeith, I. G., Nussbaum, R. L., Olanow, C. W., Ravina, B. M., Singleton, A. B., Tanner, C. M., Tro-janowski, J. Q., and Wszolek, Z. K. (2007). DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology 68, 812-819.
93. Litvan, I., Agid, Y., Calne, D., Campbell, G., Dubois, B., Duvoisin, R. C., Goetz, C. G., Golbe, L. I., Graf-man, J., Growdon, J. H., Hallett, M., Jankovic, J., Quinn, N. P., Tolosa, E., and Zee, D. S. (1996). Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 47, 1-9.
94. Mackenzie,I. R.,Neumann,M., Baborie, A., Sampathu, D. M., Du Plessis, D., Jaros, E., Perry, R. H., Tro-janowski, J. Q., Mann, D. M., and Lee, V. M. (2011a). A harmonized classification system for FTLD-TDP pathology. Acta Neuropathol. 122, 111-113.
95. Mackenzie, I. R., Neumann, M., Cairns, N. J., Munoz, D. G., and Isaacs, A. M. (2011b). Novel types of frontotem-poral lobar degeneration: beyond tau and TDP-43.J. Mol. Neurosci. 45, 402-408.
96. Mackenzie, I. R., Neumann, M., Bigio, E. H., Cairns, N. J., Alafuzoff, I., Kril, J., Kovacs, G. C., Ghetti, B., Halliday, G., Holm, I. E., Ince, P. G., Kam-phorst, W., Revesz, T., Rozemuller, A. J., Kumar-Singh, S., Akiyama, H., Baborie, A.,Spina,S., Dickson,D. W., Trojanowski, J. Q., and Mann, D. M. (2010a). Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol. 119, 1-4.
97. Mackenzie, I. R., Rademakers, R., and Neumann, M. (2010b). TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet Neurol. 9, 995-1007.
98. McKhann, G., Drachman, D. A., Folstein, M., Katzman, R., Price, D. L., and Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer's disease - report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34, 939-944.
99. McKeith, I., Mintzer, J., Aarsland, D., Burn, D., Chiu, H., Cohen-Mansfield, J., Dickson, D., Dubois, B., Duda, J. E., Feldman, H., Gauthier, S., Halliday, G., Lawlor, B., Lippa, C., Lopez, O. L., Carlos Machado, J., O'Brien, J., Playfer, J., and Reid, W. (2004). Dementia with Lewy bodies. Lancet Neurol. 3, 19-28.
100. McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feld-man, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., Aars-land, D., Arai, H., Ballard, C. G., Boeve, B., Burn, D. J., Costa, D., Del Ser, T., Dubois, B., Galasko, D., Gauthier, S., Goetz, C. G., Gomez-Tortosa, E., Halliday, G., Hansen, L. A., Hardy, J., Iwatsubo, T., Kalaria, R. N., Kaufer, D., Kenny, R. A., Kor-czyn, A., Kosaka, K., Lee, V. M., Lees,A., Litvan, I., Londos, E., Lopez, O. L., Minoshima, S., Mizuno, Y., Molina, J. A., Mukaetova-Ladinska, E. B., Pasquier, F., Perry, R. H., Schulz, J. B., Trojanowski, J. Q., and Yamada, M. (2005). Diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium. Neurology. 65, 1863-1872.
101. McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., Lennox, G., Quinn, N. P., Edwardson, J. A., Ince, P. G., Bergeron, C., Burns, A., Miller, B. L., Lovestone, S., Coller-ton, D., Jansen, E. N., Ballard, C., de Vos, R. A., Wilcock, G. K., Jellinger, K. A., and Perry, R. H. (1996). Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 47, 1113-1124.
102. Mesulam, M., Wicklund, A., Johnson, N., Rogalski, E., Léger, G. C., Rade-maker, A., Weintraub, S., and Bigio, E. H. (2008). Alzheimer and fron-totemporal pathology in subsets of primary progressive aphasia. Ann. Neurol. 63, 709-719.
103. Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., van Belle, G., and Berg, L. (1991). The Consortium to Establish a Registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41, 479-486.
104. Montine, T. J., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., and Dickson, D. W. (2012). National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. Acta Neuropathol. 123, 1-11.
105. Morgan,K.(2011). Threenew pathways leading to Alzheimer's disease. Neuropathol. Appl. Neurobiol. 37, 353- 357.
106. Munoz, D. G., Morris, H. R., and Rossor, M. (2011). " Picks disease," in Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders, eds D. W. Dick-son and R. O. Weller (Chichester: Wiley-Blackwell), 156-164.
107. Neary, D., Snowden, J. S., Gustafson, L., Passant, U., Stuss, D., Black, S., Freedman, M., Kertesz, A., Robert, P. H., Albert, M., Boone, K., Miller, B.L., Cummings, J., and Benson,D. F. (1998). Frontotemporal lobardegeneration: a consensus on clinical diagnostic criteria. Neurology 51, 1546-1554.
108. Neary, D., Snowden, J. S., and Mann, D. M. (2005). Frontotemporal dementia. Lancet Neurol. 4, 771-780.
109. Nelson, P. T., Jicha, G. A., Kryscio, R. J., Abner, E. L., Schmitt, F. A., Cooper, G., Xu, L. O., Smith, C. D., and Markesbery, W. R. (2010). Low sensitivity in clinical diagnoses of dementia with Lewy bodies. J. Neurol. 257, 359-366.
110. Neumann, M., Rademakers, R., Roeber, S.,Baker, M.,Kretzschmar,H. A.,and Mackenzie, I. R. (2009). A new subtype of frontotemporal lobar degeneration with FUS pathology. Brain 132, 2922-2931.
111. Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Mic-senyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C.M., McCluskey, L. F., Miller,B. L., Masliah, E., Mackenzie, I.R., Feldman, H., Feiden, W., Kret-zschmar, H., Trojanowski, J. Q., andLee, V. M. (2006). Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130-133.
112. Nishimura, M., Namba, Y., Ikeda, K., and Oda, M. (1992). Glial fibrillary tangles with straight tubules in the brains of patients with progressive supranuclear palsy. Neurosci. Lett. 143, 35-38.
113. Oksengard, A. R., Cavallin, L., Axels-son, R., Andersson, C., Nägga, K., Winblad, B., Eriksdotter-Jönhagen, M., and Wahlund, L. O. (2010). Lack of accuracy for the proposed " Dubois criteria" in Alzheimer's disease: a validation study from the Swedish brain power initiative. Dement. Geriatr. Cogn. Disord. 30, 374-380.
114. Parkkinen, L., Pirttilä, T., and Alafu-zoff, I. (2008). Applicability of current staging/categorization of alpha-synuclein pathology and their clinical relevance. Acta Neuropathol. 115, 399-407.
115. Pickering-Brown, S. M., Rollinson, S., Du Plessis, D., Morrison, K. E., Varma, A., Richardson, A. M., Neary, D., Snowden, J. S., and Mann, D. M. (2008). Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort: comparison with patients with MAPT and no known mutations. Brain 131, 721-731.
116. Podewils, L. J., Guallar, E., Kuller, L. H., Fried, L. P., Lopez, O. L., Carlson, M., and Lyketsos, C. G. (2005). Physical activity, APOE genotype, and dementia risk: findings from the Cardiovascular Health Cognition Study. Am. J. Epidemiol. 161, 639-651.
117. Ratnavalli, E., Brayne, C., Dawson, K., and Hodges,J. R. (2002). The prevalence of frontotemporal dementia. Neurology 58, 1615-1621.
118. Rebeiz,J. J.,Kolodny, E. H., and Richardson, E. P. Jr. (1967). Corticodenta-tonigral degeneration with neuronal achromasia: a progressive disorder of late adult life. Trans. Am. Neurol. Assoc. 92, 23-26.
119. Reitz, C., Brayne, C., and Mayeux, R. (2011). Epidemiology of Alzheimer disease. Nat. Rev. Neurol. 7, 137-152.
120. Renner, J. A., Burns, J. M., Hou, C. E., McKeel, D. W., Storandt, M., and Morris, J. C. (2004). Progressive posterior cortical dysfunction: a clin-icopathologic series. Neurology 63, 1175-1180.
121. Renton, A. E., Majounie, E., Waite, A., Simón-Sánchez, J., Rollinson, S., Gibbs, J. R., Schymick, J. C., Laaksovirta, H., van Swieten, J. C., Myllykangas, L., Kalimo, H., Paetau, A., Abramzon, Y., Remes, A. M., Kaganovich, A., Scholz, S. W., Duckworth, J., Ding, J., Harmer, D. W., Hernandez, D. G., Johnson, J. O., Mok, K., Ryten, M., Trabzuni, D., Guerreiro, R. J., Orrell, R. W., Neal, J., Murray, A., Pearson, J., Jansen, I. E., Sondervan, D., Seelaar, H., Blake, D., Young, K., Halliwell, N., Callister, J. B., Toul-son, G., Richardson, A., Gerhard, A., Snowden, J., Mann, D., Neary, D., Nalls, M. A., Peuralinna, T., Jans-son, L., Isoviita, V. M., Kaivorinne, A. L., Hölttä-Vuori, M., Ikonen, E., Sulkava, R., Benatar, M., Wuu, J., Chiò, A., Restagno, G., Borghero, G., Sabatelli, M., Italsgen Consortium, Heckerman, D., Rogaeva, E., Zinman, L., Rothstein, J. D., Sendt-ner, M., Drepper, C., Eichler, E. E., Alkan, C., Abdullaev, Z., Pack, S. D., Dutra, A., Pak, E., Hardy, J., Singleton, A., Williams, N. M., Heutink, P., Pickering-Brown, S., Morris, H. R., Tienari, P. J., and Traynor, B. J. (2011). A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72, 257-268.
122. Riley,K. P., Snowdon, D.A.,and Markesbery, W. R. (2002). Alzheimer's neu-rofibrillary pathology and the spectrum of cognitive function: findings from the Nun Study. Ann. Neurol. 51, 567-577.
123. Roe, C. M., Xiong, C., Miller, J. P., and Morris, J. C. (2007). Education and Alzheimer disease without dementia: support for the cognitive reserve hypothesis. Neurology 68, 223-228.
124. Roeber, S., Mackenzie, I. R., Kret-zschmar, H. A., and Neumann, M. (2008). TDP-43-negative FTLD-U is a significant new clinico-pathological subtype of FTLD. Acta Neuropathol. 116, 147-157.
125. Rohrer, J. D., Lashley, T., Schott, J. M., Warren, J. E., Mead, S., Isaacs, A. M., Beck, J., Hardy, J., de Silva, R., Warrington, E., Troakes, C., Al-Sarraj, S., King, A., Borroni, B., Clarkson, M. J., Ourselin, S., Holton, J. L., Fox, N. C., Revesz, T., Rossor, M. N., and Warren, J. D. (2011). Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration. Brain 134, 2565-2581.
126. Rohrer, J. D., Warren, J. D., Omar, R., Mead, S., Beck, J., Revesz, T., Holton, J., Stevens, J. M., Al-Sarraj, S., Pickering-Brown, S. M., Hardy, J., Fox, N. C., Collinge, J., Warring-ton, E. K., and Rossor, M. N. (2008). Parietal lobe deficits in frontotem-poral lobar degeneration caused by a mutation in the progranulin gene. Arch. Neurol. 65, 506-513.
127. Rosso, S. M., Donker Kaat, L., Baks, T., Joosse, M., de Koning, I., Pijnenburg, Y., de Jong, D., Dooijes, D., Kamphorst, W., Ravid, R., Nier-meijer, M. F., Verheij, F., Kremer, H. P., Scheltens, P., van Duijn, C. M., Heutink, P., and van Swieten, J. C. (2003). Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population-based study. Brain 126, 2016-2022.
128. Saito, Y., Kawashima, A., Ruberu, N. N., Fujiwara, H., Koyama, S., Sawabe, M., Arai, T., Nagura, H., Yamanouchi, H., Hasegawa, M., Iwatsubo, T., and Murayama, S. (2003). Accumulation of phospho-rylated alpha-synuclein in aging human brain. J. Neuropathol. Exp. Neurol. 62, 644-654.
129. Saunders, A. M., Strittmatter, W. J., Schmechel, D., George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., Hulette, C., Crain, B., Goldgaber, D., and Roses, A. (1993). Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43, 1467-1472.
130. Scaravilli, T., Tolosa, E., and Ferrer, I. (2005). Progressive supranuclear palsy and corticobasal degeneration: lumping versus splitting. Mov. Dis-ord. 20, S21-S28.
131. Seelaar, H., Rohrer, J. D., Pijnenburg, Y. A., Fox, N. C., and van Swieten, J. C. (2011). Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review. J. Neurol. Neurosurg. Psychiatr. 82, 476-486.
132. Selikhova, M., Williams, D. R., Kemp-ster, P. A., Holton, J. L., Revesz, T., and Less, A. J. (2009). A clin-icopathological study of subtypes in Parkinson's disease. Brain 132, 2947-2957.
133. Snowden, J., Neary, D., and Mann, D. (2007). Frontotemporal lobar degeneration: clinical and pathological relationships. Acta Neuropathol. 114, 31-38.
134. Snowden, J. S., Hu, Q., Rollinson, S., Halliwell, N., Robinson, A., Davidson, Y. S., Momeni, P., Baborie, A., Griffiths, T. D., Jaros, E., Perry, R. H., Richardson, A., Pickering-Brown, S. M., Neary, D., and Mann, D. M. (2011). The most common type of FTLD-FUS (aFTLD-U) is associated with a distinct clinical form of frontotemporal dementia but is not relatedtomutationsintheFUS gene. Acta Neuropathol. 122, 99-110.
135. Stewart, H., Rutherford, N. J., Briem-berg, H., Krieger, C., Cashman, N., Fabros, M., Baker, M., Fok, A., Dejesus-Hernandez, M., Eisen, A., Rademakers, R., and Mackenzie, I. R. (2012). Clinical and pathological features of amyotrophic lateral sclerosis caused by mutation in the C9ORF72 gene on chromosome 9p. Acta Neuropathol. 123, 409-417.
136. Taipa, R., Tuna, A., Damásio, J., Pinto, P. S., Cavaco, S.,
137. Tang-Wai, D. F., Graff-Radford, N. R., Boeve, B. F., Dickson, D. W., Parisi, J. E., Crook, R., Caselli, R. J., Knop-man, D. S., and Petersen, R. C. (2004). Clinical, genetic, and neu-ropathologic characteristics of posterior cortical atrophy. Neurology 63, 1168-1174.
138. Taylor, K. I., Probst, A., Miserez, A. R., Monsch, A. U., and Tolnay, M. (2008). Clinical course of neu-ropathologically confirmed frontal-variant Alzheimer's disease. Nat. Clin. Pract. Neurol. 4, 226-232.
139. Thal, D. R., Sassing, I., Schultz, C., Haass, C., Braak, E., and Braak, H. (1999). Fleecy amyloid deposits in the internal layers of the human entorhinal cortex are comprised of N-terminal truncated fragments of Abeta. J. Neuropathol. Exp. Neurol. 58, 210-216.
140. Urwin, H., Josephs, K. A., Rohrer, J. D., Mackenzie, I. R., Neumann, M., Authier, A., Seelaar, H., Van Swieten, J. C., Brown, J. M., Johannsen, P., Nielsen, J. E., Holm, I. E., FReJA Consortium, Dickson, D. W., Rade-makers, R., Graff-Radford, N. R., Parisi, J. E., Petersen, R. C., Hatan-paa, K. J., White, C. L. III, Weiner, M. F., Geser, F., Van Deerlin, V. M., Tro-janowski, J. Q., Miller, B. L., Seeley, W. W., van der Zee, J., Kumar-Singh, S., Engelborghs, S., De Deyn, P. P., Van Broeckhoven, C., Bigio, E. H., Deng, H. X., Halliday, G. M., Kril, J. J., Munoz, D. G., Mann, D. M., Pickering-Brown, S. M., Doodeman, V., Adamson, G., Ghazi-Noori, S., Fisher, E. M., Holton, J. L., Revesz, T., Rossor, M. N., Collinge, J., Mead, S., and Isaacs, A. M. (2010). FUS pathology defines the majority of tau and TDP-43-negative frontotemporal lobar degeneration. Acta Neu-ropathol. 120, 33-41.
141. van Swieten, J. C., and Heutink, P. (2008). Mutations in progranulin (GRN) within the spectrum of clinical and pathological phenotypes of frontotemporal dementia. Lancet Neurol. 7, 965-974.
142. Vekrellis, K., Xilouri, M., Emmanouili-dou, E., Rideout, H. J., and Stefanis, L. (2011). Pathological roles of α-synuclein in neurological disorders. Lancet Neurol. 10, 1015-1025.
143. Wadia, P. M., and Lang,A. E. (2007). The many faces of corticobasal degeneration. Parkinsonism Relat. Disord. 13, S336-S340.
144. Wang, D., and Munoz, D. G. (1995). Qualitative and quantitative differences in senile plaque dys-trophic neuritis of Alzheimer's disease and normal aged brain. J. Neuropathol. Exp. Neurol. 54, 548-556.
145. Wisniewski, H. M., Sadowski, M., Jakubowska-Sadowska, K., Tar-nawski, M., and Wegiel, J. (1998). Diffuse, lake-like amyloid-beta deposits in the parvopyramidal layer of the presubiculum in Alzheimer disease. J. Neuropathol. Exp. Neurol. 57, 674-683.
146. Yamada, T., Mcgeer, P. L., and Mcgeer, E. G. (1992). Appearance of paired nucleated, Tau-positive glia in patients with progressive supranu-clear palsy brain tissue. Neurosci. Lett. 135, 99-102.